Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Lutenizing hormone releasing factor ; related peptides
Reexamination Certificate
2005-07-05
2005-07-05
Weber, Jon (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Lutenizing hormone releasing factor ; related peptides
C530S328000, C530S334000, C530S338000, C530S344000, C424S009100, C424S185100, C514S002600, C514S506000
Reexamination Certificate
active
06914121
ABSTRACT:
PEG-LHRH analog conjugates, where a PEG moiety is covalently bound to a serine residue of a LHRH analog either directly or via a bifunctional linker molecule, such as an amino acid, and methods for producing these conjugates are provided in the present invention. Also provided are a pharmaceutical composition and a method for treating pathologies in which LHRH analog administration is beneficial.
REFERENCES:
patent: 5840900 (1998-11-01), Greenwald et al.
patent: 0 377 585 (1995-07-01), None
patent: 0 377 665 (1995-07-01), None
patent: 94/04193 (1994-03-01), None
patent: 94/27641 (1994-12-01), None
patent: 96/21469 (1996-07-01), None
patent: 96/21489 (1998-07-01), None
Emons G. et al., Recent Results cancer Res. 124, 55-68 (1992).
El-Roeiy A. et al., Curr. Opin. Obstet. Gynecol. 2 (2) 166-172 (1990).
Karten M. J. et al., Endocrine Reviews vol. 7, No. 1, 44-66 1986).
Nicholson R. I. et al., Cancer Treat. Res. 39, 1-23 (1988).
Kolb V. M. Prog. Drug. Res. 42, 39-52 (1992).
Klijn J.G.M., Recent Results cancer Res. 124, 75-90 (1992).
Felix et al., “Site-Specific Poly(ethylene glycol)ylation of Peptides”,American Chemical Society, 218-238 (1997).
XP-002114783 ABSTRACT—“Peptide(s) modified with polyethylene glycol—e.g. calcitonin GRP, elastase, etc. have prolonged activity” Jun. 25, (1991), for JP 03148298 by Sano et al.
XP-002068523 Zalipsky—“Functionalized Poly(ethylene glycol) for Preparation of Biologically Relevant Conjugates”,Bioconjugate Chem., 6:150-165 (1995).
Felix et al., “Site-Specific Poly(ethylene glycol)ylation of Peptides”,American Chemical Society, 218-238 (1997).
XP-002114783 ABSTRAST—“Peptide(s) modified with polyethylene glycol—e.g. calcitonin GRP, elastase, etc.have prolonged activity” (1991).
XP-002068523 Zalipsky—“Functionalized Poly(ethylene glycol) for Preparation of Biologically Relevant Conjugates”,Bioconjugate Chem., 6:150-165 (1995).
Bentley Michael D.
El-Tayar Nabil
Zhao Xuan
Applied Research Systems Ars Holding N.V.
Browdy and Neimark
Kam Chih-Min
Weber Jon
LandOfFree
PEG-LHRH analog conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PEG-LHRH analog conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PEG-LHRH analog conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3394687